Skip to main content
. 2018 Jul 11;45(13):2264–2273. doi: 10.1007/s00259-018-4083-3

Fig. 6.

Fig. 6

Overall survival in relation to alkaline phosphatase (ALP) response among patients with elevated total ALP at baseline (≥10% vs. <10% reduction from baseline; 34 responders, 6 nonresponders). Median survival times: 256 days in ALP responders, and 137 days in ALP nonresponders. Median follow-up times: 325 days in ALP responders, and 216 days in ALP nonresponders. *p = 0.03 vs. ALP responders